CORT
Corcept Therapeutics
$91.12
−$4.24 (−4.45%)Jul 27, 2026
Key metrics
The numbers that frame CORT today
- Market cap
- $9.78B
- P/E (TTM)
- 209.6
- EV / FCF
- 80.8
- Gross margin
- 98.3%
- EV / Sales
- 12.6
- ROIC
- -1.6%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $28.66
- 52wk High
- $97.63
Growth
Revenue and earnings trend for CORT
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about CORT
Is Corcept Therapeutics a good buy?
Yes. Corcept Therapeutics has excellent quality and excellent momentum. Both signals support the setup. Growth looks poor, a caveat that does not overturn the setup. We think Corcept Therapeutics is selling at a high price, which cuts against the buy case.
What is the market capitalization of CORT?
Corcept Therapeutics's market capitalization is $9.78B.
What is the P/E ratio for CORT stock?
Corcept Therapeutics's current P/E ratio is 209.6.
What is the 52-week high for CORT stock?
The 52-week high for Corcept Therapeutics is $97.63. The current close of $91.12 is 6.7% below that high.
What is the 52-week low for CORT stock?
The 52-week low for Corcept Therapeutics is $28.66. The current close of $91.12 is 217.9% above that low.
Does CORT stock pay dividends?
Corcept Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for CORT?
Corcept Therapeutics's Debt / Equity ratio is 0.02.